Astria Therapeutics, Inc. (ATXS)

Jan 26, 2026 - ATXS was delisted (reason: acquired by BCRX)

12.58

0.00 (0.00%)

Inactive · Last trade price on Jan 22, 2026

Astria Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 21, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Cap	718	505	315	488	70	43
Market Cap Growth	50.24%	60.09%	-35.36%	594.91%	63.24%	-41.51%
Enterprise Value	590.19	277.07	164.27	358.46	41.42	-0.9
Last Close Price	12.58	8.94	7.68	14.89	5.39	12.84
PB Ratio	5.15	1.58	1.30	2.20	0.57	1.06
P/TBV Ratio	3.13	1.57	0.95	0.98	0.39	0.97
EV/EBITDA Ratio	-	-	-	-	-	0.02
EV/EBIT Ratio	-	-	-	-	-	0.02
EV/FCF Ratio	-	-	-	-	-	0.03
Debt / Equity Ratio	0.02	0.02	0.00	0.00	0.00	0.03
Quick Ratio	10.42	17.15	21.34	24.99	24.12	7.03
Current Ratio	10.78	17.49	21.73	25.13	24.42	7.25
Return on Equity (ROE)	-44.90%	-33.52%	-31.40%	-30.18%	-239.19%	-97.66%
Return on Assets (ROA)	-44.45%	-37.37%	-34.22%	-29.88%	-222.87%	-83.90%
Return on Invested Capital (ROIC)	-1186.63%	3380.03%	2254.11%	1504.16%	6448.69%	5038.36%
Return on Capital Employed (ROCE)	-47.77%	-39.40%	-35.74%	-31.12%	-238.68%	-96.22%
Buyback Yield / Dilution	-14.24%	-86.44%	-106.03%	-63.81%	-191.81%	-63.87%
Total Shareholder Return	-14.24%	-86.44%	-106.03%	-63.81%	-191.81%	-63.87%

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q